Abiopharma

🔍 Sutton Mark S (Executive)

Company: KROGER CO (KR)

Report Date: 2026-09-01

Detailed Transactions and Holdings:

• Holds 0 shares of Common Stock (Direct)
  Date: 2026-09-01 | Code: H | shares_owned_after: 46,004.00
• Acquired 50 shares of Phantom Stock - Incentive Shares (Derivative)
  Date: 2026-09-01 | Code: A | equity_swap_involved: false | shares_owned_after: 7,474.82 | transaction_form_type: 4 | Footnotes: F1, F2, F3, F3

Footnotes:

• F1: Each phantom share represents the right to receive one common share upon distribution from the deferred compensation account.
• F2: Represents phantom stock acquired in dividend reinvestment transactions under a deferred compensation plan of The Kroger Co.
• F3: Shares of phantom stock will be distributed following termination of the reporting person's services as an Independent Director of The Kroger Co.